Health Canada maintains use of COVID prevention drug Evusheld despite FDA pullback
Published
Health Canada says it will continue to recommend COVID-19 prevention drug, Evulsheld, despite U.S. FDA pulling back its emergency use authorization due to concerns around its efficacy against Omicron subvariant 'Kraken.'
Full Article